[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619213":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":45,"centralContacts":46,"locations":52,"responsibleParty":76,"collaborators":80,"id":83,"slug":45,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":84,"sex":90,"minAge":91,"maxAge":45,"enrollmentInfo":92,"targetDuration":45,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":55,"whyStopped":45,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care","ACTIVE_COMPARATOR","The usual care group will receive standard care, including physio- and occupational therapy if admitted to the hospital, and potentially referral to rehabilitation in the municipality three months after transplantation.",[13],"Procedure: Usual care",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care plus the prehabilitation intervention","EXPERIMENTAL","The prehabilitation group will in addition to usual care receive supervised individually tailored resistance training and optimized nutritional support",[19,20,13],"Other: Resistance training","Dietary Supplement: Nutritional Support",[22,29,37],{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"Resistance training","Structured and supervised, group-based, resistance training 3x per week (individually tailored to the individual's capabilities)",[15],[27,28],"Exercise","Prehabilitation",{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DIETARY_SUPPLEMENT","Nutritional Support","Optimized dietary counseling and supplementation to optimize nutritional intake",[15],[28,35,36],"dietary counseling","nutrition",{"type":38,"name":9,"description":39,"armGroupLabels":40,"otherNames":41},"PROCEDURE","Usual care is the standard care before allogeneic hematopoietic stem cell transplantation",[9,15],[42,43,44],"HSCT","allogeneic hematopoietic stem cell transplantation","hematopoietic stem cell transplantation",null,[47],{"name":48,"role":49,"phone":50,"phoneExt":45,"email":51},"Jan Christensen, PhD","CONTACT","+4522479075","jan.christensen.02@regionh.dk",[53],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":57,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Copenhagen University Hospital - Rigshospitalet","RECRUITING","Copenhagen","Denmark","2100","DK",{"type":61,"coordinates":62},"Point",[63,64],12.56553,55.67594,{"lat":64,"lon":63},[67,71,74],{"name":68,"role":49,"phone":69,"phoneExt":45,"email":70},"Magnus N Bech, PhD Student","+4535453484","magnus.nygaard.bech@regionh.dk",{"name":72,"role":73,"phone":45,"phoneExt":45,"email":45},"Lone S Friis, Senior physician hematologist","SUB_INVESTIGATOR",{"name":75,"role":73,"phone":45,"phoneExt":45,"email":45},"Mary Jarden, Professor",{"type":77,"investigatorFullName":78,"investigatorTitle":79,"investigatorAffiliation":5,"oldNameTitle":45,"oldOrganization":45},"PRINCIPAL_INVESTIGATOR","Jan Christensen","Senior Researcher and Head of Research",[81],{"name":82,"class":6},"Aarhus University Hospital","100619213",false,"NCT07341698","Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation","Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Alloge-neic Hematopoietic Stem Cell Transplantation - a National Randomized Controlled Trial","PrepAllo","Inclusion Criteria:\n\nAdult patients \\>18 years will be eligible for inclusion if they are scheduled for a allo-HSCT with at least four weeks before their scheduled transplantation date.\n\nExclusion Criteria:\n\n* pregnancy\n* physical or mental disabilities precluding test of muscle function\n* inability to read and understand Danish or English","ALL","18 Years",{"count":93,"type":94},110,"ESTIMATED","INTERVENTIONAL",[97],"NA","Seventy-five percent of patients treated with hematopoietic stem cell transplants survive one-year post-transplantation. However, this intensive treatment is associated with prolonged hospitalizations and significant deconditioning. Pathophysiological changes in skeletal muscle mass and function have notable implications for disease progression and long-term prognosis. Patients frequently report substantial rehabilitation needs, though these needs are highly individualized and fluctuate over time, with musculoskeletal dysfunction and fa-tigue being the most common barriers to prehabilitation. Furthermore, at least 35% of cancer patients are found to have inadequate daily protein intake, which may hinder improve-ments in physical performance through prehabilitation. Several recent studies have demonstrated the safety and feasibility of exercise-based prehabilitation interventions during the pre-transplant period. However, no full-scale randomized controlled trial (RCT) has been conducted to date.",[100],"Allogeneic Hematopoietic Stem Cell Transplantation Recipient",[28,27,102,103],"resistance training","nutritional support","2026-01-27",{"date":106,"type":107},"2026-01-29","ACTUAL",{"date":109,"type":107},"2026-01-12",{"date":111,"type":94},"2032-10-12",{"name":5,"class":6},1]